Filter
443
Filtered Results: 443
Text search:
genome
Featured
Recommendations
57
New Publications
83
Language
Document type
No document type
177
Studies & Reports
100
Guidelines
85
Manuals
26
Strategic & Response Plan
20
Fact sheets
15
Training Material
10
Situation Updates
5
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
India
22
Global
18
Western and Central Europe
11
Germany
10
Russia
10
Latin America and the Carribbean
9
Africa
9
South Africa
7
Nigeria
6
Tanzania
6
Brazil
6
Ukraine
6
Uganda
5
Eastern Europe
5
Ethiopia
4
West and Central Africa
4
Middle East and North Africa
4
Liberia
3
Senegal
3
Chad
3
East and Southern Africa
3
South–East Asia Region
3
Sierra Leone
2
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Niger
2
Haiti
2
South Sudan
2
Kenya
2
Bangladesh
2
Peru
2
Colombia
2
Bolivia
2
Angola
2
Western Pacific Region
2
Asia
2
Venezuela
2
France
2
Spain
2
Guinea
1
Burkina Faso
1
Morocco
1
USA
1
Saudi Arabia
1
Ghana
1
Philippines
1
Somalia
1
Nepal
1
Pakistan
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Syria
1
Cambodia
1
China
1
Rwanda
1
Indonesia
1
Mauritania
1
Malawi
1
Mozambique
1
Sudan
1
Benin
1
Argentina
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
Eastern Europe and Central Asia
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Denmark
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
92
Clinical Guidelines
73
Public Health
23
Pharmacy & Technologies
18
Key Resources
14
Women & Child Health
4
Capacity Building
2
Toolboxes
COVID-19
79
TB
48
Rapid Response
45
NTDs
42
AMR
37
Mental Health
26
Zika
15
HIV
15
Planetary Health
15
Ebola
12
NCDs
10
Refugee
9
Polio
7
Conflict
4
Global Health Education
4
Caregiver
4
Disability
3
Specific Hazards
3
Pharmacy
3
Cholera
2
Health Financing Toolbox
2
South Sudan
1
Natural Hazards
1
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Public health emergencies, including pandemics, highlight the need for health systems and services that are prepared, resilient and ready to respond to health security threats. Endorsed by Member States in 2023, the Asia Pacific Health Security Action Framework (APHSAF) is designed to engage m...
Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr...
Asbestos, the most frequent cause of occupational cancer, continues to be consumed ona massive scale, with millions of people exposed on a daily basis. This review explains why we havefailed in curtailing the silent epidemic of asbestos-related disease and why the numbers of asbestosvictims are like...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
Malawi is a landlocked country with a surface area of 118,484 km2. Administratively, the country is divided into three regions, namely the Northern, Central and Southern regions. The country has 28 districts, which are further divided into traditional authorities (TA) ruled by chiefs. The TAs are su...
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
interim guidance, 25 November 2024
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
THELANCETID-D-16-00800 S1473-3099(16)30318-8
